AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2009
Aug 25, 2009
30826_dirs_2009-08-25_7d20ffd8-626a-4621-86a2-516de1cf9ca9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2009-08-24
Reporting Person: COOPER GLENN L MD (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-08-24 | Stock Option (Right to Buy) | $5.00 | A | 24000 | Acquired | 2019-08-24 | Common Stock (24000) | Direct |
Footnotes
F1: 8,000 shares become exercisable on each of 8/24/2010, 8/24/2011 and 8/24/2012.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23